Lexicon Pharmaceuticals

LXRX

LXRX
Lexicon Pharmaceuticals Stock Quote
$3.30 -$0.07 -2.1%
BATS BZX Real Time Price as of October 11, 2019, 4:00 p.m. EDT View Interactive LXRX Charts

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

News & Analysis: Lexicon Pharmaceuticals

The Fool has written over 100 articles on Lexicon Pharmaceuticals.

All

Market Moves

Earnings







What's Next for Lexicon Pharmaceuticals?

American regulators rejected a type 1 diabetes treatment that analysts predicted would eventually eclipse $450 million in annual revenue.





Interactive Chart